World of Psychology

Glaxo, Shire Strengthen Risk Warnings on ADHD Drugs

By John M. Grohol, PsyD
Founder & Editor-in-Chief

Not good news for people taking Adderall XR or Dexedrine this morning.

GlaxoSmithKline Plc and Shire Plc said they strengthened warnings that their attention-deficit drugs may cause psychological side effects and misuse may lead to sudden death from heart attacks and strokes.

Glaxo, the world’s second-largest drugmaker, said today that it added the warnings to prescribing information on its Dexedrine treatment last month. Shire said it also added the warnings for its Adderall XR, the top-selling treatment for attention deficit hyperactivity disorder.

Source: Bloomberg.com: U.K.


Comments


View Comments / Leave a Comment

This post currently has 4 comments. You can read the comments or leave your own thoughts on our new comments page.

Trackbacks

No trackbacks yet to this post.


    Last reviewed: By John M. Grohol, Psy.D. on 22 Aug 2006
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2006). Glaxo, Shire Strengthen Risk Warnings on ADHD Drugs. Psych Central. Retrieved on May 25, 2012, from http://psychcentral.com/blog/archives/2006/08/22/glaxo-shire-strengthen-risk-warnings-on-adhd-drugs/

 

Recent Comments
  • Joel Hassman, MD: Oh, and by the way, Dr Pies, here is another retort to your demand people use their real names at...
  • CandidFrank65: Interesting article. I have been living in Trinidad since 1965. The fact is that East Indians are much...
  • CARL: I AGREE WITH EVERYTHING THAT YOU HAVE SAID ABOUT INTIMACY (LOVE) NEEDS TRUST AND SAFETY. I TO HAVE STUDIED THIS...
  • Daisy: An article full of wisdom, I think! My husband and I have recently celebrated our 25th wedding...
  • Austin: To the author: “… the rest of the seminal fluid has more than 4 dozen other chemicals. One of...
Subscribe to Our Weekly Newsletter



Find a Therapist


Users Online: 4231
Join Us Now!